Skip to main content
Livermore
Livermore
ZHEN

D.A. Davidson & Co.

SEC CIK
0001080107
Latest filing
Jul 24, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
56,812
Value
$2.72M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by D.A. Davidson & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202656,812$2.72M<0.1%+1,576+2.9%AddedHolders
Q1 202655,236$2.03M<0.1%+9,605+21.0%AddedHolders
Q4 202545,631$2.32M<0.1%+5,397+13.4%AddedHolders
Q3 202540,234$2.23M<0.1%−184−0.5%ReducedHolders
Q2 202540,418$2.79M<0.1%+14,091+53.5%AddedHolders
Q1 202526,327$1.83M<0.1%−6,052−18.7%ReducedHolders
Q4 202432,379$2.79M<0.1%−18,833−36.8%ReducedHolders
Q3 202451,212$6.10M0.1%+12,399+31.9%AddedHolders
Q2 202438,813$5.54M<0.1%+7,884+25.5%AddedHolders
Q1 202430,929$3.97M<0.1%+4,364+16.4%AddedHolders
Q4 202326,565$2.75M<0.1%+3,129+13.4%AddedHolders
Q3 202323,436$2.13M<0.1%+2,724+13.2%AddedConverted for a 2-for-1 splitHolders
Q2 202310,356$1.68M<0.1%+1,457+16.4%AddedHolders
Q1 20238,899$1.41M<0.1%−293−3.2%ReducedHolders
Q4 20229,192$1.24M<0.1%+438+5.0%AddedHolders
Q3 20228,754$874.0K<0.1%−158−1.8%ReducedHolders
Q2 20228,912$993.0K<0.1%+207+2.4%AddedHolders
Q1 20228,705$967.0K<0.1%+590+7.3%AddedHolders
Q4 20218,115$908.0K<0.1%+2,219+37.6%AddedHolders
Q3 20215,896$566.0K<0.1%+600+11.3%AddedHolders
Q2 20215,296$444.0K<0.1%+105+2.0%AddedHolders
Q1 20215,191$350.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.